Lv1
30 积分 2023-11-27 加入
STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors
8天前
已完结
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T‐Cell Engager, in Prostate Cancer Patients
10天前
已完结
Engineering of acidic pH-responsive anti-CD3 binding antibodies
18天前
已完结
Acidosis orchestrates adaptations of energy metabolism in tumors
1个月前
已完结
Prediction of VH–VL domain orientation for antibody variable domain modeling
1个月前
已完结
An improved model of association for VH–VL immunoglobulin domains: Asymmetries between VH and VL in the packing of some interface residues
1个月前
已完结
A versatile platform for the tumor-targeted delivery of immune checkpoint-blocking immunoglobin G
1个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1个月前
已完结
Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia
3个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
3个月前
已完结
皖公网安备34019202002308
